News
Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...
Panelists discuss how a woman aged 55 years with T3N1M0 locally advanced squamous cell carcinoma represents a typical case for definitive chemoradiation therapy over surgical resection, emphasizing ...
From Guidelines to Practice: Clinical Perspectives on Mitomycin-Based Chemoradiation for Anal Cancer
Panelists discuss how the evolution of anal cancer treatment began with the 1974 Nigro regimen combining 5-fluorouracil and ...
The chemoradiotherapy platforms used for the treatment of head and neck cancer are described, together with suggestions about integrating novel agents such as EGFR inhibitors and antiangiogenic drugs.
Neoadjuvant immunotherapy plus chemoradiation can be safely administered in carefully selected patients with MIBC and 2-year survival outcomes are promising, according to the investigators.
Chemoradiation improves survival in cervical cancer, but benefits decline after age 80, with chemotherapy offering less impact on cancer-specific survival in older patients.
Adding atezolizumab to concurrent chemoradiation did not improve overall survival in a phase 3 trial of patients with LS-SCLC.
Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III ...
Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III ...
According to a new study from experts at the University of Michigan Health Rogel Cancer Center, some oropharynx cancer patients may qualify for less radiation treatments. This could assist many ...
Hypofractionated concurrent chemoradiation (cCRT) at doses higher than usual followed by an adaptive stereotactic ablative radiotherapy (SABR) boost showed promising safety and efficacy in ...
Study: Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Image Credit: Prrrettty/Shutterstock.com Background Cancer and immune cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results